D. Osborne

Direttore Finanziario/CFO presso Melt Pharmaceuticals, Inc.

45 anni

Health Technology

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Helen Sabzevari	M	62	PRECIGEN, INC.	5 anni
Larry Dillaha	M	60	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	3 anni
Jeffrey Perez	M	52	PRECIGEN, INC.	10 anni
Fred Hassan	M	78	PRECIGEN, INC.	8 anni
Jeffrey Kindler	M	68	PRECIGEN, INC.	13 anni
James Turley	M	68	PRECIGEN, INC.	10 anni
Vinita Deshbandhu Gupta	F	56	PRECIGEN, INC.	7 anni
Arthur Laffer	M	83	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	2 anni
Mark Baum	M	51	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	-
J. Corley	M	68	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	5 anni
Steven M. Harasym	M	-	PRECIGEN, INC.	6 anni
John Berdahl	M	-	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	-
Giovanni de Castro	M	-	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	3 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Samuel Broder	M	79	PRECIGEN, INC.	2 anni
Thomas David Reed	M	58	PRECIGEN, INC.	22 anni
Robert Beech	M	71	PRECIGEN, INC.	8 anni
Robert Shapiro	M	85	PRECIGEN, INC.	12 anni
Larry D. Horner	M	90	PRECIGEN, INC.	7 anni
Marie L. Rossi	M	-	PRECIGEN, INC.	9 anni
Thomas Shrader	M	-	PRECIGEN, INC.	-
Olivier R. Jarry	M	63	PRECIGEN, INC.	-
James Vincent Lambert	M	60	PRECIGEN, INC.	1 anni
Rick Sterling	M	60	PRECIGEN, INC.	14 anni
Jack Anthony Bobo	M	58	PRECIGEN, INC.	-
Dana di Ferdinando	F	-	PRECIGEN, INC.	-
Christopher Basta	M	-	PRECIGEN, INC.	-
Kelly Huang	M	55	PRECIGEN, INC.	-
Grace Colón	M	57	PRECIGEN, INC.	2 anni
Andy Bass	M	-	PRECIGEN, INC.	-
Fayaz Khazi	M	51	PRECIGEN, INC.	2 anni
Thomas Bostick	M	67	PRECIGEN, INC.	3 anni
Timothy D. Kasbe	M	58	PRECIGEN, INC.	-
Ena Chan Cratsenburg	F	-	PRECIGEN, INC.	-
Jayson M. Rieger	M	48	PRECIGEN, INC.	1 anni
Nir Nimrodi	M	55	PRECIGEN, INC.	5 anni
Robert F. Walsh	M	65	PRECIGEN, INC.	6 anni
Geno Germano	M	63	PRECIGEN, INC.	1 anni
Matthew Crisp	M	41	PRECIGEN, INC.	1 anni
Peter Emtage	M	-	PRECIGEN, INC.	-
Hadyn Parry	M	-	PRECIGEN, INC.	-
Peter Seufer-Wasserthal	M	-	PRECIGEN, INC.	5 anni
Joel A. Liffmann	M	63	PRECIGEN, INC.	4 anni
Krish S. Krishnan	M	59	PRECIGEN, INC.	5 anni
Saiid Zarrabian	M	71	PRECIGEN, INC.	1 anni
Andrew Last	M	64	PRECIGEN, INC.	1 anni
Suma M. Krishnan	F	59	PRECIGEN, INC.	4 anni
Gregory Ian Frost	M	52	PRECIGEN, INC.	1 anni
Chris Savile	M	-	PRECIGEN, INC.	4 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	48	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni

Borsa valori
Insiders
D. Osborne
Contatti personali